AU4651500A - Compositions and methods for therapy and diagnosis of head/neck and lung squamous cell carcinoma - Google Patents

Compositions and methods for therapy and diagnosis of head/neck and lung squamous cell carcinoma

Info

Publication number
AU4651500A
AU4651500A AU46515/00A AU4651500A AU4651500A AU 4651500 A AU4651500 A AU 4651500A AU 46515/00 A AU46515/00 A AU 46515/00A AU 4651500 A AU4651500 A AU 4651500A AU 4651500 A AU4651500 A AU 4651500A
Authority
AU
Australia
Prior art keywords
diagnosis
therapy
neck
compositions
head
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU46515/00A
Inventor
Davin C. Dillon
Tongtong Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of AU4651500A publication Critical patent/AU4651500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • C12N9/6491—Matrix metalloproteases [MMP's], e.g. interstitial collagenase (3.4.24.7); Stromelysins (3.4.24.17; 3.2.1.22); Matrilysin (3.4.24.23)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4741—Keratin; Cytokeratin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
AU46515/00A 1999-04-23 2000-04-21 Compositions and methods for therapy and diagnosis of head/neck and lung squamous cell carcinoma Abandoned AU4651500A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US13090699P 1999-04-23 1999-04-23
US60130906 1999-04-23
US09533870 2000-04-20
PCT/US2000/010687 WO2000065053A2 (en) 1999-04-23 2000-04-21 Compositions and methods for therapy and diagnosis of head/neck and lung squamous cell carcinoma

Publications (1)

Publication Number Publication Date
AU4651500A true AU4651500A (en) 2000-11-10

Family

ID=22446911

Family Applications (1)

Application Number Title Priority Date Filing Date
AU46515/00A Abandoned AU4651500A (en) 1999-04-23 2000-04-21 Compositions and methods for therapy and diagnosis of head/neck and lung squamous cell carcinoma

Country Status (4)

Country Link
EP (1) EP1173570A2 (en)
AU (1) AU4651500A (en)
CA (1) CA2370482A1 (en)
WO (1) WO2000065053A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003040317A2 (en) * 2001-11-02 2003-05-15 Pfizer Products Inc. Lung cancer therapeutics and diagnostics
CN103397096A (en) * 2013-08-05 2013-11-20 浙江天科高新技术发展有限公司 Biomarker for detecting hepatocellular carcinoma and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5424191A (en) * 1992-05-20 1995-06-13 The United States Of America As Represented By The Department Of Health And Human Services Epithelial cell specific differentiation marker
US5633161A (en) * 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor

Also Published As

Publication number Publication date
WO2000065053A2 (en) 2000-11-02
CA2370482A1 (en) 2000-11-02
WO2000065053A3 (en) 2001-07-19
EP1173570A2 (en) 2002-01-23

Similar Documents

Publication Publication Date Title
AU2001261007A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
PL354093A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU1656501A (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU2495200A (en) Compositions and methods for the treatment of tumor
AU7994200A (en) Compositions and methods for therapy and diagnosis of prostate cancer
AU4185100A (en) Compounds for therapy and diagnosis of lung cancer and methods for their use
AU2001283360A1 (en) Methods for diagnosis and therapy of hematological and virus-associated malignancies
AU7710300A (en) Methods for diagnosis and therapy of hematological and virus-associated malignancies
AU2001249549A1 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
AU4300701A (en) Methods and compositions for administration of therapeutic reagents
MXPA02004770A (en) Therapeutic compositions and methods of use thereof.
AU3887900A (en) Protamine fragment compositions and methods of use
AU2002311909A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2002219229A1 (en) Means for the diagnosis and therapy of CTCL
AU2469101A (en) Methods for inducing atrial and ventricular rhythms using ultrasound and microbubbles
AUPQ155799A0 (en) Therapeutic methods and uses
AU2002359330A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU4680699A (en) Methods of delivering aerosolized polynucleotides to the respiratory tract
AU2002303219A1 (en) Compositions and methods for the therapy and diagnosis of cancer
AU2003260241A1 (en) Buguzhi agent and composition and methods of preparing and administering the same
AU2001259062A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
EP1168918A4 (en) Vaccines and gene therapy compositions and methods of making and using the same

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase